Masucci G - Search Results

1

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.

Ascierto PA, Atkins M, Bifulco C, Botti G, Cochran A, Davies M, Demaria S, Dummer R, Ferrone S, Formenti S, Gajewski TF, Garbe C, Khleif S, Kiessling R, Lo R, Lorigan P, Arthur GM, Masucci G, Melero I, Mihm M, Palmieri G, Parmiani G, Puzanov I, Romero P, Schilling B, Seliger B, Stroncek D, Taube J, Tomei S, Zarour HM, Testori A, Wang E, Galon J, Ciliberto G, Mozzillo N, Marincola FM, Thurin M. Ascierto PA, et al. Among authors: masucci g. J Transl Med. 2015 Nov 30;13:374. doi: 10.1186/s12967-015-0736-1. J Transl Med. 2015. PMID: 26619946 Free PMC article.

2

Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression.

Matsuda M, Salazar F, Petersson M, Masucci G, Hansson J, Pisa P, Zhang QJ, Masucci MG, Kiessling R. Matsuda M, et al. Among authors: masucci g, masucci mg. J Exp Med. 1994 Dec 1;180(6):2371-6. doi: 10.1084/jem.180.6.2371. J Exp Med. 1994. PMID: 7964510 Free PMC article.

3

Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity.

Kono K, Salazar-Onfray F, Petersson M, Hansson J, Masucci G, Wasserman K, Nakazawa T, Anderson P, Kiessling R. Kono K, et al. Among authors: masucci g. Eur J Immunol. 1996 Jun;26(6):1308-13. doi: 10.1002/eji.1830260620. Eur J Immunol. 1996. PMID: 8647210

4

Efficient harvest of in vivo IL-2-activated CD3+ lymphocytes for adoptive immunotherapy by selective leukapheresis (lymphocytapheresis).

Masucci G, Svensson A, Hansson M, Hansson J, Nakazawa T, Salazar F, Petersson M, Kiessling R. Masucci G, et al. J Hematother. 1997 Jun;6(3):253-60. doi: 10.1089/scd.1.1997.6.253. J Hematother. 1997. PMID: 9234180 Clinical Trial.

5

Synthetic peptides derived from the melanocyte-stimulating hormone receptor MC1R can stimulate HLA-A2-restricted cytotoxic T lymphocytes that recognize naturally processed peptides on human melanoma cells.

Salazar-Onfray F, Nakazawa T, Chhajlani V, Petersson M, Kärre K, Masucci G, Celis E, Sette A, Southwood S, Appella E, Kiessling R. Salazar-Onfray F, et al. Among authors: masucci g. Cancer Res. 1997 Oct 1;57(19):4348-55. Cancer Res. 1997. PMID: 9331097

6

Cells and cytokines in immunotherapy and gene therapy of cancer.

Pawelec G, Rees RC, Kiessling R, Madrigal A, Dodi A, Baxevanis C, Gambacorti-Passerini C, Masucci G, Zeuthen J. Pawelec G, et al. Among authors: masucci g. Crit Rev Oncog. 1999;10(1-2):83-127. Crit Rev Oncog. 1999. PMID: 10327211 Review.

7

A short-term dietary supplementation of high doses of vitamin E increases T helper 1 cytokine production in patients with advanced colorectal cancer.

Malmberg KJ, Lenkei R, Petersson M, Ohlum T, Ichihara F, Glimelius B, Frödin JE, Masucci G, Kiessling R. Malmberg KJ, et al. Among authors: masucci g. Clin Cancer Res. 2002 Jun;8(6):1772-8. Clin Cancer Res. 2002. PMID: 12060616

8

Frequent loss of HLA-A2 expression in metastasizing ovarian carcinomas associated with genomic haplotype loss and HLA-A2-restricted HER-2/neu-specific immunity.

Norell H, Carlsten M, Ohlum T, Malmberg KJ, Masucci G, Schedvins K, Altermann W, Handke D, Atkins D, Seliger B, Kiessling R. Norell H, et al. Among authors: masucci g. Cancer Res. 2006 Jun 15;66(12):6387-94. doi: 10.1158/0008-5472.CAN-06-0029. Cancer Res. 2006. PMID: 16778217

9

A short-term dietary supplementation with high doses of vitamin E increases NK cell cytolytic activity in advanced colorectal cancer patients.

Hanson MG, Ozenci V, Carlsten MC, Glimelius BL, Frödin JE, Masucci G, Malmberg KJ, Kiessling RV. Hanson MG, et al. Among authors: masucci g. Cancer Immunol Immunother. 2007 Jul;56(7):973-84. doi: 10.1007/s00262-006-0261-4. Epub 2006 Dec 2. Cancer Immunol Immunother. 2007. PMID: 17143612 Free PMC article. Clinical Trial.

10

Analysis of HLA class I-II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancer.

Gamzatova Z, Villabona L, van der Zanden H, Haasnoot GW, Andersson E, Kiessling R, Seliger B, Kanter L, Dalianis T, Bergfeldt K, Masucci GV. Gamzatova Z, et al. Among authors: masucci gv. Tissue Antigens. 2007 Sep;70(3):205-13. doi: 10.1111/j.1399-0039.2007.00875.x. Tissue Antigens. 2007. PMID: 17661908

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters